Abstract
An effective method to quantify the parasite loads is the key to the evaluation of anti-cryptosporidial drug efficacy in vitro. However, high-throughput screening (HTS) of drugs against Cryptosporidium parvum in vitro was impractical by the labor-intensive traditional assays. Here we describe a simplified quantitative RT-PCR assay suitable for HTS of compounds and for evaluating drug efficacy against the growth of C. parvum in vitro.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bessoff K, Sateriale A, Lee KK, Huston CD (2013) Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother 57(4):1804–1814. https://doi.org/10.1128/AAC.02460-12
Zhang H, Zhu G (2015) Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro. Front Microbiol 6:991. https://doi.org/10.3389/fmicb.2015.00991
Cai X, Woods KM, Upton SJ, Zhu G (2005) Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimicrob Agents Chemother 49(11):4437–4442. https://doi.org/10.1128/AAC.49.11.4437-4442.2005
Upton SJ, Tilley M, Brillhart DB (1994) Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol Lett 118(3):233–236
Upton SJ, Tilley M, Brillhart DB (1995) Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. J Clin Microbiol 33(2):371–375
Arrowood MJ, Sterling CR (1987) Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J Parasitol 73(2):314–319
Suresh P, Rehg JE (1996) Comparative evaluation of several techniques for purification of Cryptosporidium parvum oocysts from rat feces. J Clin Microbiol 34(1):38–40
Glasel JA (1995) Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. BioTechniques 18(1):62–63
Iversen PW, Benoit Beck B, Yun-Fei Chen Y, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Montrose C, Moore RA, Weidner JR, Sittampalam GS (2012) HTS Assay Validation. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD. http://www.ncbi.nlm.nih.gov/books/NBK53196/
Acknowledgments
This research was supported in part by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under award number R21AI099850.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhang, H., Zhu, G. (2020). High-Throughput Screening of Drugs Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR. In: Mead, J., Arrowood, M. (eds) Cryptosporidium. Methods in Molecular Biology, vol 2052. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9748-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9748-0_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9747-3
Online ISBN: 978-1-4939-9748-0
eBook Packages: Springer Protocols